Oric Pharmaceuticals, Inc. ORIC Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $45.67M-23.1% | $59.41M+154% | $23.38M-65.0% | $66.84M-70.4% | ||
| $235.82M+20.0% | $196.55M+6.4% | $184.8M+32.5% | $139.43M+1,171% | ||
| $31.75M+10.1% | $28.85M+68.9% | $17.08M-15.2% | $20.14M+58.3% | ||
| $288.47M+10.0% | $262.25M+23.4% | $212.6M+1.0% | $210.46M-12.5% | ||
| $2.42M-17.4% | $2.92M+2.2% | $2.86M-12.0% | $3.25M+34.8% | ||
| $7.25M-19.2% | $8.97M-7.5% | $9.7M-15.8% | $11.52M-6.5% | ||
| $110.76M— | $0-100% | $26.85M+22.3% | $21.95M-49.4% | ||
| $408.89M+49.2% | $274.14M+8.8% | $252.01M+2.0% | $247.18M-17.2% | ||
| $3.82M+147% | $1.55M+64.0% | $944K-28.5% | $1.32M-30.0% | ||
| $16.59M-28.8% | $23.3M+19.4% | $19.51M+38.7% | $14.07M+6.1% | ||
| $3.33M+4.6% | $3.18M+15.7% | $2.75M+3.5% | $2.66M+38.1% | ||
| $20.42M-17.8% | $24.85M+21.4% | $20.46M+32.9% | $15.39M+1.6% | ||
| $4.11M-33.4% | $6.17M-17.2% | $7.46M-21.0% | $9.44M-10.2% | ||
| $24.53M-20.9% | $31.02M+11.1% | $27.92M+12.5% | $24.83M-3.3% | ||
| $0— | $0— | $0— | $0— | ||
| $11K+57.1% | $7K+16.7% | $6K+20.0% | $5K+25.0% | ||
| $1.08B+33.6% | $805.51M+22.3% | $658.75M+18.1% | $557.87M+7.7% | ||
| -$692.24M-23.0% | -$562.77M-29.4% | -$434.93M-30.1% | -$334.23M-36.4% | ||
| $786K+107% | $379K+46.9% | $258K+120% | -$1.29M-1,153% | ||
| $384.36M+58.1% | $243.12M+8.5% | $224.09M+0.8% | $222.35M-18.5% | ||
| $408.89M+49.2% | $274.14M+8.8% | $252.01M+2.0% | $247.18M-17.2% | ||
| $235.82M+20.0% | $196.55M+6.4% | $184.8M+32.5% | $139.43M+1,171% | ||
| $7.25M-19.2% | $8.97M-7.5% | $9.7M-15.8% | $11.52M-6.5% | ||
| $110.76M— | $0-100% | $26.85M+22.3% | $21.95M-49.4% | ||
| $7.25M-19.2% | $8.97M-7.5% | $9.7M-15.8% | $11.52M-6.5% | ||
| $7.25M-19.2% | $8.97M-7.5% | $9.7M-15.8% | $11.52M-6.5% | ||
| $16.59M-28.8% | $23.3M+19.4% | $19.51M+38.7% | $14.07M+6.1% | ||
| $16.59M-28.8% | $23.3M+19.4% | $19.51M+38.7% | $14.07M+6.1% | ||
| $7.44M-20.5% | $9.36M-8.4% | $10.21M-15.6% | $12.1M-2.8% | ||
| $1.08B+33.6% | $805.51M+22.3% | $658.75M+18.1% | $557.87M+7.7% | ||
| $11K+57.1% | $7K+16.7% | $6K+20.0% | $5K+25.0% | ||
| $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Oric Pharmaceuticals, Inc.'s total assets?
- Oric Pharmaceuticals, Inc. (ORIC) holds $436.8M in total assets, up 79.8% year over year.
- How much debt does Oric Pharmaceuticals, Inc. have?
- Oric Pharmaceuticals, Inc. carries $3.3M in total debt against $415.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Oric Pharmaceuticals, Inc. have?
- Oric Pharmaceuticals, Inc. holds $56.4M in cash and equivalents.
- Can Oric Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 16.33 — current assets exceed current liabilities.
- Where does Oric Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.